Esketamine outperforms one of the standard drugs for treatment-resistant major depression

A major clinical trial shows that the drug, esketamine, one of the two main forms of ketamine, outperforms one of the standard treatments for treatment-resistant major depression.

Breakthrough research identifies fibrin as key factor in preterm brain bleeds

Mark Petersen, MD, has seen firsthand the devastating effects of brain bleeds in premature babies. It’s an exceedingly common condition that affects up to 20

July 24, 2024

AI’s expert-level image analysis can be built on flawed rationales: study

Dive Brief: A recent study showed that a version of ChatGPT analyzes medical images at an expert level but frequently reached the right answer with

July 26, 2024

Clinical Challenges: Family Planning in Multiple Sclerosis

A proactive approach to reproductive planning that starts well before pregnancy and continues through to postpartum support can help women with multiple sclerosis (MS) achieve

October 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.